Home > Press > Picosun Issues Stock Incentive Plan
Abstract:
Leading Atomic Layer Deposition systems manufacturer Picosun Oy, Finland issued 200,000 new equity stocks as it made public a stock award plan for its employees and members of the Board of Directors. The total stock award plan represents eight percent of the present total equity of Picosun Oy.
Picosun Issues Stock Incentive Plan
Helsinki, Finland | Posted on November 23rd, 2008
"A fifth of the new stock was reserved for future key members of the staff, and the rest was subscribed to by current employees and members of the Board of Directors," says Mr. Kustaa Poutiainen, President and Chief Executive Officer of Picosun.
"So far, effects of the global economic crisis have not been felt at Picosun. We currently have a full dozen ALD reactors on our assembly line, and interest from both production and research clients world-wide has, if anything, increased," Poutiainen explains.
According to Mr. Poutiainen, the current stock award plan follows an internal corporate timeline which, in five years time, leads to an Initial Public Offering (IPO). "Next on the agenda is a venture capital investment aimed at fuelling our strong growth," he says.
####
About Picosun Oy
Picosun is an international ALD equipment manufacturer with world-wide sales and service organization. Picosun develops and manufactures Atomic Layer Deposition reactors for micro- and nanotechnology applications. Picosun represents continuity to over three decades of ALD reactor manufacturing in Finland. Picosun provides its customers with versatile, reliable and user-friendly ALD process tools, which offer unique scalability from research to production. Picosun is based in Espoo, Finland and has its US headquarters in Detroit, Michigan. SUNALET ALD process tools are installed in various universities, research institutes and companies across Europe, USA and Asia.
Dr Tuomo Suntola, inventor of ALD technology, is Member of the Board of Directors of Picosun. World's most experienced ALD reactor designer Sven Lindfors is Picosun´s Chief Technology Officer and one of the founders of the company. Picosun Oy is a part of Stephen Industries Inc Oy.
For more information, please click here
Contacts:
Picosun Oy
Mr. Juhana Kostamo, Managing Director
Tietotie 3
FI-02150 Espoo, Finland
Tel. +358 50 321 1955
Fax. +358 20 722 7012
Copyright © Picosun Oy
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
News and information
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Investments/IPO's/Splits
Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013
Harris & Harris Group Notes Carl Zeiss' Planned Acquisition of Xradia June 13th, 2013
Long Island Capital Alliance Announces Participants for Biotech Technology Transfer Capital Forum: Event to Be Held on June 14 in Collaboration With Cold Spring Harbor Laboratory June 8th, 2013
Iran to Hold Int'l Forum on Nanotechnology Economy (IFNE2013) May 30th, 2013
Announcements
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Tools
Beneq’s comprehensive industrial Thin Film Coating Services shorten time to market June 18th, 2013
Which qubit my dear? New method to distinguish between neighbouring quantum bits June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Hitachi announces the SU8200 – a new type of cold field emitter SEM June 17th, 2013